Additional hemoperfusion is associated with improved overall survival and self-reported sleep disturbance in patients on hemodialysis

Abstract

Introduction:

Patients with maintenance hemodialysis have experienced long-standing sleep disturbance. In this study, we attempted to explore whether long-term hemoperfusion could improve sleep and increase the overall survival in hemodialysis patients.

Methods:

A total of 158 patients, who underwent routine hemodialysis, were assessed in this study. These patients were computer-matched into two groups, with one group including 80 patients with absolute hemodialysis and the other consisting of 78 cases with hemodialysis in combination with hemoperfusion. Hemoperfusion was performed 1–2 times biweekly, with each session lasting 2 h. Self-reported sleep disturbance was evaluated before and after the observational time (2-year period); sleep quality was measured using the Pittsburgh Sleep Quality Index.

Findings:

Using multivariate regression analyses, we found sleep duration was associated with age, diabetes, low income, pruritus, hyperphosphatemia, hypercalcemia, high parathyroid hormone, and hemoglobin (P < 0.001). The overall survival rate of the hemodialysis in combination with hemoperfusion group was significantly higher than that of the absolute hemodialysis group (P < 0.05) after adjusting for sex, age, and diabetes. A 2-year hemoperfusion therapy was associated with improved sleep disturbance and sleep efficiency; this was accompanied by an increase in nocturnal melatonin levels. Furthermore, there was a significant difference in the first hospitalization between the hemodialysis and hemodialysis in combination with hemoperfusion groups (P < 0.01).

Discussion:

Our results indicated that hemoperfusion in combination with hemodialysis is associated with an increase in the overall survival and improved sleep disorders in hemodialysis patients.

Keywords

Hemodialysis hemoperfusion sleep disturbance overall survival

Get full access to this article

View all access options for this article.

References

Makar

Pun

PH.

Sudden cardiac death among hemodialysis patients. Am J Kidney Dis 2017; 69(5): 684–695.

Mavrakanas

Charytan

DM.

Cardiovascular complications in chronic dialysis patients. Curr Opin Nephrol Hypertens 2016; 25(6): 536–544.

Stevens

Wood

Koshiaris

et al . Blood pressure variability and cardiovascular disease: systematic review and meta-analysis. BMJ 2016; 354: i4098.

Parker

Bliwise

Bailey

et al . Daytime sleepiness in stable hemodialysis patients. Am J Kidney Dis 2003; 41(2): 394–402.

Perl

Unruh

Chan

CT.

Sleep disorders in end-stage renal disease: “markers of inadequate dialysis”?

Kidney Int 2006; 70(10): 1687–1693.

Maung

El Sara

Chapman

et al . Sleep disorders and chronic kidney disease. World J Nephrol 2016; 5(3): 224–232.

Novak

Shapiro

Mendelssohn

et al . Diagnosis and management of insomnia in dialysis patients. Semin Dial 2006; 19(1): 25–31.

Ricardo

Goh

Chen

et al . Association of sleep duration, symptoms, and disorders with mortality in adults with chronic kidney disease. Kidney Int Rep 2017; 2(5): 866–873.

Zhang

Mei

Rong

et al . Effect of the combination of hemodialysis and hemoperfusion on clearing advanced glycation end products: a prospective, randomized, two-stage crossover trial in patients under maintenance hemodialysis. Blood Purif 2015; 40(2): 127–132.

10.

Chen

Jiang

Shan

et al . Combination of maintenance hemodialysis with hemoperfusion: a safe and effective model of artificial kidney. Int J Artif Organs 2011; 34(4): 339–347.

11.

Hirshkowitz

Whiton

Albert

et al . National Sleep Foundation’s sleep time duration recommendations: methodology and results summary. Sleep Health 2015; 1(1): 40–43.

12.

Mathur

Kumar

Crawford

et al . A multicenter, randomized, double-blind, placebo-controlled trial of nalbuphine ER tablets for uremic pruritus. Am J Nephrol 2017; 46(6): 450–458.

13.

Williams

Han

et al . Physical activity and sleep patterns in hemodialysis patients in a suburban environment. Blood Purif 2017; 43(1–3): 235–243.

14.

Kim

Lee

Kim

et al . Acupuncture and related interventions for symptoms of chronic kidney disease. Cochrane Database Syst Rev. Epub ahead of print 28 June 2016. DOI: 10.1002/14651858.CD009440.pub2.

15.

Wikström

Itchy skin—a clinical problem for haemodialysis patients. Nephrol Dial Transplant 2007; 22(Suppl. 5): v3–v7.

16.

Pisoni

Wikström

Elder

et al . Pruritus in haemodialysis patients: international results from the dialysis outcomes and practice patterns study (DOPPS). Nephrol Dial Transplant 2006; 21(12): 3495–3505.

17.

Combs

Teixeira

Germain

MJ.

Pruritus in kidney disease. Semin Nephrol 2015; 35: 383–391.

18.

Scherer

Combs

Brennan

Sleep disorders, restless legs syndrome, and uremic pruritus: diagnosis and treatment of common symptoms in dialysis patients. Am J Kidney Dis 2017; 69(1): 117–128.

19.

Kittanamongkolchai

El-Zoghby

Eileen Hay

et al . Charcoal hemoperfusion in the treatment of medically refractory pruritus in cholestatic liver disease. Hepatol Int 2017; 11(4): 384–389.

20.

Macia

Avilés

Navarro

et al . Efficacy of molecular adsorbent recirculating system for the treatment of intractable pruritus in cholestasis. Am J Med 2003; 114(1): 62–64.

21.

Yin

Chen

et al . Curative effect of neutral macroporous resin hemoperfusion on treating hemodialysis patients with refractory uremic pruritus. Medicine 2017; 96(12): e6160.

22.

Meyer

Hostetter

TH.

Uremia. N Engl J Med 2007; 357: 1316–1325.

23.

FHN Trial Group, Chertow

Levin

et al . In-center hemodialysis six times per week versus three times per week. N Engl J Med 2010; 363(24): 2287–2300.

24.

Rocco

Lockridge

Jr Beck

et al . The effects of frequent nocturnal home hemodialysis: the frequent hemodialysis network nocturnal trial. Kidney Int 2011; 80(10): 1080–1091.

25.

Hall

Larive

Painter

et al . Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: frequent hemodialysis network (FHN) randomized trials. Clin J Am Soc Nephrol 2012; 7(5): 782–794.

26.

Unruh

Larive

Chertow

et al . Effects of 6-times-weekly versus 3-times-weekly hemodialysis on depressive symptoms and self-reported mental health: frequent hemodialysis network (FHN) trials. Am J Kidney Dis 2013; 61(5): 748–758.

27.

Kraus

Fluck

Weinhandl

et al . Intensive hemodialysis and health-related quality of life. Am J Kidney Dis 2016; 68(5S1): S33–S42.

28.

Unruh

Larive

Eggers

et al . The effect of frequent hemodialysis on self-reported sleep quality: frequent hemodialysis network trials. Nephrol Dial Transplant 2016; 31(6): 984–991.

29.

Kennedy

Ryan

Kane

et al . The impact of change of renal replacement therapy modality on sleep quality in patients with end-stage renal disease: a systematic review and meta-analysis. J Nephrol 2018; 31(1): 61–70.

30.

Gade

Blaschke

Rodenbeck

et al . Uremic restless legs syndrome (RLS) and sleep quality in patients with end-stage renal disease on hemodialysis: potential role of homocysteine and parathyroid hormone. Kidney Blood Press Res 2013; 37(4–5): 458–463.

31.

Mehta

Drawz

PE.

Is nocturnal blood pressure reduction the secret to reducing the rate of progression of hypertensive chronic kidney disease?

Curr Hypertens Rep 2011; 13(5): 378–385.

32.

Karasek

Szuflet

Chrzanowski

et al . Decreased melatonin nocturnal concentrations in hemodialyzed patients. Neuro Endocrinol Lett 2005; 26(6): 653–656.

33.

Koch

van der Putten

Van Someren

et al . Impairment of endogenous melatonin rhythm is related to the degree of chronic kidney disease (CREAM study). Nephrol Dial Transplant 2010; 25(2): 513–519.

34.

Russcher

Nagtegaal

Nurmohamed

et al . The effects of kidney transplantation on sleep, melatonin, circadian rhythm and quality of life in kidney transplant recipients and living donors. Nephron 2015; 129(1): 6–15.

35.

Kancheva

Sulková

Svára

et al . Increase of nocturnal melatonin levels in hemodialyzed patients after parathyroidectomy: a pilot study. Physiol Res 2008; 57(Suppl. 1): S181–S185.